The Antibody Engineering & Therapeutics virtual event welcomed over 800 attendees over the course of the 3-day program in mid-December. Featuring a slate of keynote presentations built into the live agenda, and an on-demand library of over 100 pre-recorded speaker presentations, it was packed with content.
A highlight of the event was the collection of 45-minute panel discussions which brought every speaker from the meeting into the live agenda for active discussions and audience Q&A.
Keynote presentations included Pamela Bjorkman of Caltech on The Structural Basis of Neutralization by Antibodies Against Viral Fusion Proteins, Paul Carter of Genentech on Engineering Bispecific Antibodies as Therapeutics and Andrew Ward of Scripps on Characterizing Polyclonal Antibody Responses Using Single Particle Electron Microscopy.
Two live award presentations were featured during the event including a student/post-doc best poster award and the inaugural Jim Huston science talent award presentation. A stirring tribute session honoring Jim Huston, the founder of the Antibody Society and long-time organizer of the conference (he passed away in 2020), featured live tributes from some of the most famous antibody scientists in the field.
We also introduced several new features, including a speed networking session and small group hot topic discussion sessions.
We look forward to welcoming everyone back to Antibody Engineering & Therapeutics in San Diego in 2021.
Stay safe and well,
Michael Keenan, Conference Producer, TIDES Europe
1. Key Themes of the Week: Executive Summary
Biology and bioinformatics consultant Silvia Hnatova looks back on the top presentation highlights across the week, including:
Keynote: The Structural Basis of Neutralization by Antibodies Against Viral Fusion Proteins
2. Panel Discussion: Bispecific T Cell Engagers
Silvia Hnatova revisits this popular discussion which explored the current challenges of T cell engager antibodies as cancer therapeutics.
3. Advancing Therapeutic Antibody Discovery Using RenMab/RenLite/RenMab KO Immunoglobulin Humanized Mouse Platforms
In this on-demand session, Dr. Li Hui presents a powerful tool for advancing current bispecific or multispecific antibody discovery.
4. Panel Discussion: Antibody Affinity Maturation and Developability Improvement for Lead Optimization
Silvia Hnatova highlights the key themes of one of the conference’s hottest live discussions on antibody affinity maturation and developability improvements
5. Poster: RenMab Mouse: A Leading Platform for Fully Human Antibody Generation
This poster and presentation explains the development and features of Biocytogen’s fully human antibody mouse.
6. The Antibody Society Student/PostDoc Poster Competition Winners
Take a look at the full presentations and posters by innovative winners Felix Goerdeler and Nicolas Bery.
7. Novel TNFR2 humanized mouse model for in vivo validation of human TNFR2 antibody targeting hTNF /hTNFR2 signaling pathways
In this poster presentation, Biocytogen presents a useful preclinical model for in vivo efficacy of human TNFR2 therapeutics.
